Catherine C. Dawson-Gore MD, MSc , Emily K. Myers MD , Emily H. Cooper MS , Lauren L. Evans MD , Steven G. Schauer DO , Shannon Acker MD
{"title":"最小的遭受中风:在创伤质量改善计划数据库中了解钝性脑血管损伤儿童的中风和治疗模式","authors":"Catherine C. Dawson-Gore MD, MSc , Emily K. Myers MD , Emily H. Cooper MS , Lauren L. Evans MD , Steven G. Schauer DO , Shannon Acker MD","doi":"10.1016/j.surg.2025.109353","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Stroke rate and treatment patterns for children with blunt cerebrovascular injury are not well-described. There exists a gap in knowledge of how children with blunt cerebrovascular injury are treated, the stroke rate associated with antithrombotic therapy, and the optimal time to start treatment.</div></div><div><h3>Methods</h3><div>A retrospective review of the Trauma Quality Improvement Program database was conducted from 2016 to 2022 for children with blunt injury (<18 years) with blunt cerebrovascular injury. Analysis of all children with blunt cerebrovascular injury and subgroups of children without traumatic brain injury, as well as those without contraindications to antithrombotic therapy (no traumatic brain injury, solid-organ injury, or blood transfusion within 24 hours) was performed. Stroke rate and treatment patterns were compared between age groups (0–6, 7–11, 12–14, 15–17 years) and injury grades.</div></div><div><h3>Results</h3><div>Among 685,631 blunt injured children, 2,336 incurred blunt cerebrovascular injury (0.34%). Stroke rate was greatest in the youngest patients (6.2% 0–6 years; 2.0% 7–11 years) who had the lowest rates of antithrombotic therapy. Fifty-two percent of patients received no antithrombotic therapy during their hospitalization. Children who received antithrombotic therapy had greater rates of stroke compared with those untreated (6.1% vs 2.1%, <em>P</em> < .001) regardless of age group. Low-molecular weight heparin was the most common antithrombotic therapy (28.2%) followed by heparin (14.2%), and aspirin (5.1%).</div></div><div><h3>Conclusion</h3><div>Children aged 0–11 years had the greatest rates of stroke and were least likely to receive antithrombotic therapy. More than one half of children did not receive antithrombotic therapy. Patients who received antithrombotic therapy had greater stroke rates than untreated patients, which may reflect antithrombotic therapy given after stroke occurred. Treatment guidelines are needed for children with blunt cerebrovascular injury.</div></div>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"183 ","pages":"Article 109353"},"PeriodicalIF":3.2000,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The smallest suffer stroke: Understanding stroke and treatment patterns in children with blunt cerebrovascular injury within the Trauma Quality Improvement Program database\",\"authors\":\"Catherine C. Dawson-Gore MD, MSc , Emily K. Myers MD , Emily H. Cooper MS , Lauren L. Evans MD , Steven G. Schauer DO , Shannon Acker MD\",\"doi\":\"10.1016/j.surg.2025.109353\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Stroke rate and treatment patterns for children with blunt cerebrovascular injury are not well-described. There exists a gap in knowledge of how children with blunt cerebrovascular injury are treated, the stroke rate associated with antithrombotic therapy, and the optimal time to start treatment.</div></div><div><h3>Methods</h3><div>A retrospective review of the Trauma Quality Improvement Program database was conducted from 2016 to 2022 for children with blunt injury (<18 years) with blunt cerebrovascular injury. Analysis of all children with blunt cerebrovascular injury and subgroups of children without traumatic brain injury, as well as those without contraindications to antithrombotic therapy (no traumatic brain injury, solid-organ injury, or blood transfusion within 24 hours) was performed. Stroke rate and treatment patterns were compared between age groups (0–6, 7–11, 12–14, 15–17 years) and injury grades.</div></div><div><h3>Results</h3><div>Among 685,631 blunt injured children, 2,336 incurred blunt cerebrovascular injury (0.34%). Stroke rate was greatest in the youngest patients (6.2% 0–6 years; 2.0% 7–11 years) who had the lowest rates of antithrombotic therapy. Fifty-two percent of patients received no antithrombotic therapy during their hospitalization. Children who received antithrombotic therapy had greater rates of stroke compared with those untreated (6.1% vs 2.1%, <em>P</em> < .001) regardless of age group. Low-molecular weight heparin was the most common antithrombotic therapy (28.2%) followed by heparin (14.2%), and aspirin (5.1%).</div></div><div><h3>Conclusion</h3><div>Children aged 0–11 years had the greatest rates of stroke and were least likely to receive antithrombotic therapy. More than one half of children did not receive antithrombotic therapy. Patients who received antithrombotic therapy had greater stroke rates than untreated patients, which may reflect antithrombotic therapy given after stroke occurred. Treatment guidelines are needed for children with blunt cerebrovascular injury.</div></div>\",\"PeriodicalId\":22152,\"journal\":{\"name\":\"Surgery\",\"volume\":\"183 \",\"pages\":\"Article 109353\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-04-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0039606025002053\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0039606025002053","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
The smallest suffer stroke: Understanding stroke and treatment patterns in children with blunt cerebrovascular injury within the Trauma Quality Improvement Program database
Background
Stroke rate and treatment patterns for children with blunt cerebrovascular injury are not well-described. There exists a gap in knowledge of how children with blunt cerebrovascular injury are treated, the stroke rate associated with antithrombotic therapy, and the optimal time to start treatment.
Methods
A retrospective review of the Trauma Quality Improvement Program database was conducted from 2016 to 2022 for children with blunt injury (<18 years) with blunt cerebrovascular injury. Analysis of all children with blunt cerebrovascular injury and subgroups of children without traumatic brain injury, as well as those without contraindications to antithrombotic therapy (no traumatic brain injury, solid-organ injury, or blood transfusion within 24 hours) was performed. Stroke rate and treatment patterns were compared between age groups (0–6, 7–11, 12–14, 15–17 years) and injury grades.
Results
Among 685,631 blunt injured children, 2,336 incurred blunt cerebrovascular injury (0.34%). Stroke rate was greatest in the youngest patients (6.2% 0–6 years; 2.0% 7–11 years) who had the lowest rates of antithrombotic therapy. Fifty-two percent of patients received no antithrombotic therapy during their hospitalization. Children who received antithrombotic therapy had greater rates of stroke compared with those untreated (6.1% vs 2.1%, P < .001) regardless of age group. Low-molecular weight heparin was the most common antithrombotic therapy (28.2%) followed by heparin (14.2%), and aspirin (5.1%).
Conclusion
Children aged 0–11 years had the greatest rates of stroke and were least likely to receive antithrombotic therapy. More than one half of children did not receive antithrombotic therapy. Patients who received antithrombotic therapy had greater stroke rates than untreated patients, which may reflect antithrombotic therapy given after stroke occurred. Treatment guidelines are needed for children with blunt cerebrovascular injury.
期刊介绍:
For 66 years, Surgery has published practical, authoritative information about procedures, clinical advances, and major trends shaping general surgery. Each issue features original scientific contributions and clinical reports. Peer-reviewed articles cover topics in oncology, trauma, gastrointestinal, vascular, and transplantation surgery. The journal also publishes papers from the meetings of its sponsoring societies, the Society of University Surgeons, the Central Surgical Association, and the American Association of Endocrine Surgeons.